hVIVO Successfully Completes Respiratory Virus Human Challenge Study
(Alliance News) - Clinical development firm hVIVO PLC said on Tuesday that it has completed the respiratory syncytial virus human challenge study on 60-75 year-old adults for positive tests found Read More